Hims & Hers Health, Inc. (HIMS) - Comprehensive Stock Analysis & Investment Research
Deep dive into Hims & Hers Health, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Hims & Hers Health, Inc. Investment Summary
When evaluating whether Hims & Hers Health, Inc. (HIMS) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Hims & Hers Health, Inc. (HIMS) operates within the Industrial Applications and Services sector, specifically in the Services-Offices & Clinics of Doctors of Medicine industry. The company employs approximately 181 people. With a market capitalization of $4 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.
Financial Performance Analysis
Our comprehensive financial analysis covers Hims & Hers Health, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Hims & Hers Health, Inc. along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Hims & Hers Health, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Hims & Hers Health, Inc. (Stock Symbol: HIMS) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Services-Offices & Clinics of Doctors of Medicine industry. The company's shares are publicly traded on the NYSE exchange.
Leadership & Workforce
Detailed information about Hims & Hers Health, Inc.'s leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Hims & Hers Health, Inc....
Sector & Industry Analysis
In-depth sector dynamics and industry context for Hims & Hers Health, Inc....
Revenue & Growth Analysis
Hims & Hers Health, Inc. generates annual revenues of $2 billion , indicating a well-established business with proven market demand.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Hims & Hers Health, Inc....
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Hims & Hers Health, Inc....
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Hims & Hers Health, Inc....
Strategic Market Position
Hims & Hers Health, Inc. strategically competes in the highly dynamic Services-Offices & Clinics of Doctors of Medicine marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.
Industry Competitive Landscape
Hims & Hers Health, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company currently shows negative free cash flow of $-43 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.
Margin & Pricing Power Analysis
The company maintains a 74.5% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.
Operating margin of -26.0% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.
Asset Utilization Efficiency
Asset turnover ratio of 0.88x indicates solid asset utilization efficiency appropriate for many manufacturing or mixed business models. This level suggests the company generates meaningful revenue from its asset base while maintaining necessary capital investments for operations.
Financial Strength & Leverage
Current ratio of 4.78 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.